RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 78 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $571,662 | +34.9% | 74,727 | +31.7% | 0.00% | – |
| Q2 2023 | $423,781 | +13.1% | 56,731 | +1.0% | 0.00% | – |
| Q1 2023 | $374,661 | -12.9% | 56,171 | +0.7% | 0.00% | – |
| Q4 2022 | $430,048 | -25.6% | 55,778 | +2.7% | 0.00% | – |
| Q3 2022 | $577,965 | +28.2% | 54,320 | -1.9% | 0.00% | – |
| Q2 2022 | $450,907 | -25.7% | 55,394 | -34.8% | 0.00% | – |
| Q1 2022 | $607,208 | -39.4% | 84,960 | +46.4% | 0.00% | -100.0% |
| Q4 2021 | $1,002,000 | +157.6% | 58,017 | +243.1% | 0.00% | – |
| Q3 2021 | $389,000 | -25.2% | 16,910 | +18.8% | 0.00% | – |
| Q2 2021 | $520,000 | – | 14,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $77,730,340 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $44,380,166 | 32.86% |
| MV Management XI, L.L.C. | 1,971,908 | $14,730,153 | 25.77% |
| MIC Capital Management UK LLP | 8,451,758 | $63,134,635 | 12.84% |
| Yong Rong (HK) Asset Management Ltd | 1,174,200 | $8,772 | 3.85% |
| ArchPoint Investors | 1,114,626 | $8,326,256 | 3.22% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,711,148 | $20,252,276 | 0.70% |
| HARVARD MANAGEMENT CO INC | 882,129 | $6,590 | 0.65% |
| Diametric Capital, LP | 119,906 | $895,698 | 0.40% |
| Lingotto Investment Management LLP | 775,077 | $5,789,825 | 0.37% |